Carregant...
High-Dose Galantamine Augmentation Inferior to Placebo on Attention, Inhibitory Control and Working Memory Performance in Nonsmokers with Schizophrenia
Dysfunction in the neuronal nicotinic acetylcholine receptor (nAChR) system has been implicated in the pathophysiology of schizophrenia, and it has been postulated that treatments that increase nAChR activity may improve symptoms of the disorder. We investigated the effects of the acetylcholinestera...
Guardat en:
| Autors principals: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2008
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2596972/ https://ncbi.nlm.nih.gov/pubmed/18325740 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.schres.2007.12.491 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|